Libo Wang
Impact in
- Parasitology top 2%
- Parasites and Host Interactions
- Parasitic Infections and Diagnostics
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
Papers in
- Oncology 11
- Pancreatic and Hepatic Oncology Research 5
- Cancer Immunotherapy and Biomarkers 4
-
- Parasites and Host Interactions 3
- Co-authors
- Xinwei Han (43 shared papers)Chunguang Guo (26 shared papers)Zaoqu Liu (29 shared papers)Long Liu (36 shared papers)Siyuan Weng (25 shared papers)Qin Dang (10 shared papers)Taoyuan Lu (11 shared papers)Zaoqu Liu (10 shared papers)
- Journals
- BMC Pediatrics (4 papers)Frontiers in Oncology (3 papers)iScience (3 papers)Journal of Cellular and Molecular Medicine (3 papers)Frontiers in Medicine (2 papers)
- Partner nations
- ChinaSwitzerlandHong Kong
In The Last Decade
Libo Wang
110 papers receiving 3.5k citations
Libo Wang's Hit Papers
Peers
Comparison fields: 5 of 105
- Parasitology 319
- Cancer Research 192
- Aging 17
- Oncology 252
- Pulmonary and Respiratory Medicine 313
Countries citing papers authored by Libo Wang
This map shows the geographic impact of Libo Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Libo Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Libo Wang more than expected).
Fields of papers citing papers by Libo Wang
This network shows the impact of papers produced by Libo Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Libo Wang. The network helps show where Libo Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Libo Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 120 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Immunosenescence: molecular mechanisms and diseases Hit paper breakdown → | 2023 | 616 |
| 2 | Machine learning-based integration develops an immune-derived lncRNA signature for improving outcomes in colorectal cancer Hit paper breakdown → | 2022 | 547 |
| 3 | 2011 | 249 | |
| 4 | 2007 | 135 | |
| 5 | 2007 | 130 | |
| 6 | 2022 | 123 | |
| 7 | BEST: a web application for comprehensive biomarker exploration on large-scale data in solid tumors Hit paper breakdown → | 2023 | 107 |
| 8 | 2008 | 99 | |
| 9 | 2022 | 81 | |
| 10 | 2022 | 77 | |
| 11 | 2009 | 56 | |
| 12 | 2021 | 53 | |
| 13 | 2020 | 51 | |
| 14 | 2021 | 51 | |
| 15 | 2021 | 45 | |
| 16 | 2022 | 41 | |
| 17 | 2023 | 41 | |
| 18 | 2012 | 40 | |
| 19 | 2021 | 39 | |
| 20 | 2021 | 38 |
About Libo Wang
Libo Wang is a scholar working on Oncology, Parasitology, Cancer Research, Pulmonary and Respiratory Medicine and Health, Toxicology and Mutagenesis, having authored 120 papers that have together received 3.5k indexed citations. Recurring topics across this work include Pneumonia and Respiratory Infections (5 papers), Air Quality and Health Impacts (5 papers), Pancreatic and Hepatic Oncology Research (5 papers), Cancer-related molecular mechanisms research (5 papers), Cancer Immunotherapy and Biomarkers (4 papers), Parasites and Host Interactions (3 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers) and COVID-19 Clinical Research Studies (3 papers). The work is most often cited by research in Parasitology (319 citations), Cancer Research (192 citations), Aging (17 citations), Oncology (252 citations) and Pulmonary and Respiratory Medicine (313 citations). Libo Wang has collaborated with scholars based in China, Switzerland and Hong Kong. Frequent co-authors include Xinwei Han, Chunguang Guo, Zaoqu Liu, Long Liu, Siyuan Weng, Qin Dang, Taoyuan Lu, Zaoqu Liu, Yuqing Ren and Peng Luo. Their work appears in journals such as BMC Pediatrics, Frontiers in Oncology, iScience, Journal of Cellular and Molecular Medicine and Frontiers in Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.